Electrochemical SARS-CoV‑2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management

• Published in: ACS applied bio materials Vol. 3; no. 11; pp. 7306 - 7325
• Main Authors: Kaushik, Ajeet Kumar, Dhau, Jaspreet Singh, Gohel, Hardik, Mishra, Yogendra Kumar, Kateb, Babak, Kim, Nam-Young, Goswami, Dharendra Yogi
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 16.11.2020
• Subjects: Artificial Intelligence; COVID-19 - epidemiology; COVID-19 - therapy; COVID-19 - virology; Electrochemical Techniques - methods; Humans; Pandemics; Point-of-Care Systems; Review; SARS-CoV-2 - isolation & purification; COVID-19 pandemic; Internet of things; diseases management; smart diagnostics; infectious diseases; smart sensing; point-of-care; artificial intelligence
• ISSN: 2576-6422; 2576-6422
• DOI: 10.1021/acsabm.0c01004

To manage the COVID-19 pandemic, development of rapid, selective, sensitive diagnostic systems for early stage β-coronavirus severe acute respiratory syndrome (SARS-CoV-2) virus protein detection is emerging as a necessary response to generate the bioinformatics needed for efficient smart diagnostics, optimization of therapy, and investigation of therapies of higher efficacy. The urgent need for such diagnostic systems is recommended by experts in order to achieve the mass and targeted SARS-CoV-2 detection required to manage the COVID-19 pandemic through the understanding of infection progression and timely therapy decisions. To achieve these tasks, there is a scope for developing smart sensors to rapidly and selectively detect SARS-CoV-2 protein at the picomolar level. COVID-19 infection, due to human-to-human transmission, demands diagnostics at the point-of-care (POC) without the need of experienced labor and sophisticated laboratories. Keeping the above-mentioned considerations, we propose to explore the compartmentalization approach by designing and developing nanoenabled miniaturized electrochemical biosensors to detect SARS-CoV-2 virus at the site of the epidemic as the best way to manage the pandemic. Such COVID-19 diagnostics approach based on a POC sensing technology can be interfaced with the Internet of things and artificial intelligence (AI) techniques (such as machine learning and deep learning for diagnostics) for investigating useful informatics via data storage, sharing, and analytics. Keeping COVID-19 management related challenges and aspects under consideration, our work in this review presents a collective approach involving electrochemical SARS-CoV-2 biosensing supported by AI to generate the bioinformatics needed for early stage COVID-19 diagnosis, correlation of viral load with pathogenesis, understanding of pandemic progression, therapy optimization, POC diagnostics, and diseases management in a personalized manner.